News Release(2008)

November 25, 2008

Filing a Marketing Authorization Application for Silodosin(Brand Name in Japan: Urief®) in Europe

October 9, 2008

Approval for SILODOSIN (Brand Name in Japan: Urief®) in the US

September 10, 2008

Conclusion of Exclusive Licensing Agreement of YSCMA, Humanized Anti-CD26 Monoclonal Antibody, for Development and Sales in Japan

June 2, 2008

Kissei Licensed Development and Sales Rights in Japan of KGTs, Novel Diabetic Medicines, to GlaxoSmithKline

February 13, 2008

New Drug Application for Silodosin (Brand name in Japan: Urief®) has been filed with FDA.

January 15, 2008

Kissei entered into a development and sales agreement with Pneuma Partners LLC on Calfactant.